Quarterly report pursuant to Section 13 or 15(d)

Summary of Stock Options Activity (Details)

v3.22.1
Summary of Stock Options Activity (Details)
 3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of Shares, Beginning Balance | shares 4,176,737
Weighted Average Exercise Price, Beginning Balance $ 2.59
Weighted Average Grant Date Fair Value, Beginning $ 2.59
Weighted Average Remaining Contractual Term (Years), Beginning 1 year 3 months 14 days
Aggregate Intrinsic Value, Beginning Balance | $ $ 14,493,284
Number of Shares, Granted | shares 200,000
Weighted Average Exercise Price, Granted $ 3.96
Weighted Average Grant Date Fair Value, Granted $ 3.59
Weighted Average Remaining Contractual Term (Years), Granted 6 years 11 months 8 days
Aggregate Intrinsic Value, Granted | $
Number of Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Number of Shares, Canceled/Expired | shares
Weighted Average Exercise Price, Canceled/Expired
Weighted Average Grant Date Fair Value, Canceled/Expired
Number of Shares, Ending Balance | shares 4,376,737
Weighted Average Exercise Price, Ending Balance $ 2.65
Weighted Average Grant Date Fair Value, Ending $ 2.65
Weighted Average Remaining Contractual Term (Years), Ending 1 year 3 months 21 days
Aggregate Intrinsic Value, Ending Balance | $ $ 8,785,846
Number of Shares, Exercisable | shares 4,176,737
Weighted Average Exercise Price, Exercisable $ 2.59
Weighted Average Grant Date Fair Value, Exercisable $ 2.59
Weighted Average Remaining Contractual Term (Years), Exercisable 1 year 14 days
Aggregate Intrinsic Value, Exercisable | $ $ 8,645,846